VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
FDMT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
FDMT4D Molecular Therapeutics, Inc.
$12.25$640M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksFDMTQuarterly Financials

4D Molecular Therapeutics, Inc. (FDMT) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

4D Molecular Therapeutics, Inc. (FDMT) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

FDMT Income Statement

Quarterly statement

FDMT Income Statement

4D Molecular Therapeutics, Inc. (FDMT) annual income statement — 9-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue3.78M3.05M85.09M90K15K14K1K3K5K28K-19K20.2M239K298K1.25M500K162K1.22M92K1.37M
Revenue Growth %25106.67%21664.29%-2900%200%-50%105.26%-99.99%-97.91%-90.6%-101.52%3940.8%47.53%-75.55%1255.43%-63.4%-98.89%-39.05%109.42%-81.59%
Cost of Goods Sold2.09M2.06M1.98M47.24M47.95M40.7M1.78M38.48M31.86M27.87M26.03M25.07M23.58M22.41M21.5M18.94M20.42M19.38M17.53M15.84M
COGS % of Revenue55.25%67.44%2.33%52486.67%319673.33%290707.14%178400%1282800%637200%99535.71%-136989.47%124.06%9867.78%7520.81%1724.14%3788%12606.17%1589.91%19052.17%1159.59%
Gross Profit1.69M992K83.11M-47.15M-47.94M-40.69M-1.78M-38.48M-31.86M-27.84M-26.05M-4.86M-23.34M-22.11M-20.25M-18.44M-20.26M-18.16M-17.44M-14.47M
Gross Margin %44.75%32.56%97.67%-52386.67%-319573.33%-290607.14%-178300%-1282700%-637100%-99435.71%137089.47%-24.06%-9767.78%-7420.81%-1624.14%-3688%-12506.17%-1489.91%-18952.17%-1059.59%
Gross Profit Growth %103.53%102.44%4761.25%-22.52%-50.48%-46.13%93.15%-691.46%-36.45%-25.9%-28.61%73.63%-15.23%-21.76%-16.16%-27.4%-3050.86%-68.65%-28.38%-250.12%
Operating Expenses78.72M74.61M68.39M14.04M11.52M12.94M54.33M12.65M10.6M10.29M10.61M9.11M8.79M7.99M8.47M8.05M8.17M8.23M7.33M8.19M
OpEx % of Revenue2081.91%2448.7%80.38%15596.67%76800%92400%5433400%421700%212020%36764.29%-55815.79%45.1%3678.24%2681.88%678.99%1611%5040.74%675.14%7965.22%599.34%
Selling, General & Admin12.52M11.69M12.77M11.84M11.52M12.94M14.63M12.65M10.6M10.29M10.61M9.11M8.79M7.99M8.47M8.05M8.17M8.23M7.33M8.19M
SG&A % of Revenue331.24%383.56%15%13152.22%76800%92400%1462700%421700%212020%36764.29%-55815.79%45.1%3678.24%2681.88%678.99%1611%5040.74%675.14%7965.22%599.34%
Research & Development68.28M64.98M57.61M49.44M47.95M40.7M43.09M38.48M31.86M27.87M26.03M25.07M23.58M22.41M21.5M18.94M20.42M19.38M17.53M15.84M
R&D % of Revenue1805.92%2132.59%67.7%54931.11%319673.33%290707.14%4308500%1282800%637200%99535.71%-136989.47%124.06%9867.78%7520.81%1724.14%3788%12606.17%1589.91%19052.17%1159.59%
Other Operating Expenses-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K
Operating Income-77.03M-73.62M14.71M-61.19M-59.46M-53.62M-56.12M-51.13M-42.46M-38.14M-36.65M-13.97M-32.14M-30.11M-28.72M-26.5M-28.43M-26.39M-24.76M-22.66M
Operating Margin %-2037.16%-2416.15%17.29%-67983.33%-396373.33%-383007.14%-5611700%-1704400%-849120%-136200%192905.26%-69.16%-13446.03%-10102.68%-2303.13%-5299%-17546.91%-2165.05%-26917.39%-1658.93%
Operating Income Growth %-29.55%-37.3%126.22%-19.66%-40.04%-40.6%-53.11%-265.91%-32.11%-26.67%-27.62%47.26%-13.05%-14.07%-15.97%-16.92%-274.22%-61.8%-21.26%-189.93%
EBITDA-74.94M-71.56M16.7M-59.18M-57.57M-51.87M-54.33M-49.43M-40.83M-36.54M-35.55M-12.98M-31.06M-29.08M-27.71M-25.98M-27.96M-25.99M-24.37M-22.28M
EBITDA Margin %-1981.91%-2348.7%19.62%-65757.78%-383786.67%-370478.57%-5433300%-1647633.33%-816640%-130507.14%187105.26%-64.24%-12994.56%-9757.38%-2221.81%-5195.6%-17259.26%-2131.75%-26493.48%-1631.11%
EBITDA Growth %-30.17%-37.98%130.73%-19.73%-40.99%-41.94%-52.84%-280.81%-31.47%-25.67%-28.31%50.03%-11.08%-11.89%-13.67%-16.59%-286.94%-63.14%-21.56%-199.19%
D&A (Non-Cash Add-back)2.09M2.06M1.98M2M1.89M1.75M1.78M1.7M1.62M1.59M1.1M994K1.08M1.03M1.01M517K466K406K390K380K
EBIT-76.86M-68.76M10.41M-56.88M-54.66M-47.97M-49.67M-43.84M-34.95M-32.4M-32.28M-13.97M-32.14M-30.11M-28.72M-26.5M-28.43M-26.39M-24.76M-22.66M
Net Interest Income4.25M4.86M4.7M4.33M4.86M5.58M6.47M7.29M7.55M5.75M4.38M3.88M2.51M1.44M1.34M795K340K100K-312K435K
Interest Income4.25M4.86M4.7M4.33M4.86M5.58M6.47M7.29M7.55M5.75M4.38M3.88M2.51M1.44M1.34M795K340K100K0435K
Interest Expense000000000000000000312K0
Other Income/Expense4.09M4.86M4.68M4.31M4.8M5.65M6.45M7.29M7.5M5.74M4.37M3.72M2.52M1.42M1.34M804K340K54K-319K422K
Pretax Income-72.94M-68.76M19.4M-56.88M-54.66M-47.97M-49.67M-43.84M-34.95M-32.4M-32.28M-10.26M-29.62M-28.68M-27.38M-25.69M-28.09M-26.34M-25.08M-22.24M
Pretax Margin %-1929.01%-2256.65%22.8%-63195.56%-364386.67%-342657.14%-4967100%-1461433.33%-699060%-115717.86%169910.53%-50.76%-12391.63%-9624.83%-2195.59%-5138.2%-17337.04%-2160.62%-27264.13%-1628.04%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-72.94M-68.76M19.4M-56.88M-54.66M-47.97M-49.67M-43.84M-34.95M-32.4M-32.28M-10.26M-29.62M-28.68M-27.38M-25.69M-28.09M-26.34M-25.08M-22.24M
Net Margin %-1929.01%-2256.65%22.8%-63195.56%-364386.67%-342657.14%-4967100%-1461433.33%-699060%-115717.86%169910.53%-50.76%-12391.63%-9624.83%-2195.59%-5138.2%-17337.04%-2160.62%-27264.13%-1628.04%
Net Income Growth %-33.44%-43.33%139.05%-29.73%-56.38%-48.06%-53.86%-327.49%-18.02%-12.97%-17.91%60.08%-5.45%-8.9%-9.15%-15.52%-270.09%-60.54%-22.08%-183.91%
Net Income (Continuing)-72.94M-68.76M19.4M-56.88M-54.66M-47.97M-49.67M-43.84M-34.95M-32.4M-32.28M-10.26M-29.62M-28.68M-27.38M-25.69M-28.09M-26.34M-25.08M-22.24M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-1.04-1.010.34-1.01-0.98-0.86-0.90-0.79-0.63-0.66-0.83-0.24-0.77-0.83-0.84-0.74-0.85-0.81-0.93-0.82
EPS Growth %-6.12%-17.44%137.78%-27.85%-55.56%-30.3%-8.43%-229.17%18.18%20.48%1.19%67.57%9.41%-2.47%9.68%9.76%-203.57%-32.79%-20.78%-127.78%
EPS (Basic)-1.04-1.010.34-1.01-0.98-0.86-0.90-0.79-0.63-0.66-0.83-0.24-0.77-0.83-0.84-0.74-0.85-0.81-0.93-0.82
Diluted Shares Outstanding70.27M68.06M57.93M56.13M55.93M55.74M53.94M55.55M55.28M49.27M39.13M42.26M38.34M32.72M32.49M32.39M32.32M32.23M27.02M27.02M
Basic Shares Outstanding70.27M68.06M57.93M56.13M55.93M55.74M53.94M55.55M55.28M49.27M39.13M42.26M38.34M32.72M32.49M32.39M32.28M32.23M27.02M27.02M
Dividend Payout Ratio--------------------